About Solute carrier family 35 member D3
Solute carrier family 35 member D3 (SLC35D3) is a protein
from Homo sapiens identified by UniProt accession
Q5M8T2, 416 residues long.
MolForge cross-references it against 0 known binders and
33 disease associations.
Target properties
| Protein name | Solute carrier family 35 member D3 |
| UniProt accession | Q5M8T2 |
| Gene | SLC35D3 |
| Organism | Homo sapiens |
| Length | 416 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (33)
Diseases linked to this target (Open Targets).
- calcium measurement · score 0.43
- blood phosphate measurement · score 0.39
- glucose measurement · score 0.33
- neurodegenerative disease · score 0.32
- type 2 diabetes mellitus · score 0.24
- Drugs used in diabetes use measurement · score 0.16
- hemoglobin A1 measurement · score 0.13
- HbA1c measurement · score 0.13
- lymphocyte percentage of leukocytes · score 0.10
- Obesity · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5M8T2-F1 | alphafold | PREDICTED | 76.59 | — |
Amino-acid sequence (416 residues)
MRQLCRGRVL GISVAIAHGV FSGSLNILLK FLISRYQFSF LTLVQCLTSS TAALSLELLR RLGLIAVPPF GLSLARSFAG VAVLSTLQSS LTLWSLRGLS LPMYVVFKRC LPLVTMLIGV LVLKNGAPSP GVLAAVLITT CGAALAGAGD LTGDPIGYVT GVLAVLVHAA YLVLIQKASA DTEHGPLTAQ YVIAVSATPL LVICSFASTD SIHAWTFPGW KDPAMVCIFV ACILIGCAMN FTTLHCTYIN SAVTTSFVGV VKSIATITVG MVAFSDVEPT SLFIAGVVVN TLGSIIYCVA KFMETRKQSN YEDLEAQPRG EEAQLSGDQL PFVMEELPGE GGNGRSEGGE AAGGPAQESR QEVRGSPRGV PLVAGSSEEG SRRSLKDAYL EVWRLVRGTR YMKKDYLIEN EELPSP
Explore Solute carrier family 35 member D3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets